Waxman Takes Legislative Driver’s Seat With Energy & Commerce Move
This article was originally published in The Tan Sheet
Executive Summary
Henry Waxman's ascent to the House Energy and Commerce Committee chair may be a pivotal development for the 111th Congress and have the most immediate impact on the pharmaceutical and supplement industries
You may also be interested in...
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture